Should drug prices be included in direct-to-consumer ads?

In June 2017, the American Medical Association issued a statement supporting consumer groups, patient advocates and other medical professional societies calls for inclusion of drug prices in direct-to-consumer (DTC) advertisements. In August this year, the Senate passed a measure that would provide the Department of Health and Human Services (HHS) with money to implement proposed rules requiring drugmakers to disclose the list price of prescription drugs in direct-to-consumer (DTC) advertising. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.